PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
12-Oct-2022 Sangamo Therapeutics Announces Updated Preliminary Phase 1/2 Data in Fabry Disease Showing Continued Tolerability and Sustained Elevated α-Gal A Enzyme Activity in Nine Patients Sangamo Therapeutics
12-Oct-2022 SiSaf’s Innovative RNA Therapeutic for Rare Genetic Skeletal Disorders Begins the U.S. Regulatory Process for Orphan Drug Designation SiSaf Ltd
12-Oct-2022 Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors Inceptor Bio
12-Oct-2022 Scottish Medicines Consortium Accepts RINVOQ®▼(upadacitinib) For Treatment of Moderately to Severely Active Ulcerative Colitis in Adults AbbVie
12-Oct-2022 Biopharma Excellence Launches Groundbreaking ‘Science Huddle’ Series With First Panel Debate on Statistical Significance in a ‘Small Data’ World Biopharma Excellence
12-Oct-2022 DEFENCE THERAPEUTICS INITIATES LUNG CANCER TREATMENT PROGRAM WITH ITS NOVEL ACCUTOXTM FORMULATION VIA INTRANASAL Defence Therapeutics Inc.
12-Oct-2022 GI Genius™ named to FORTUNE 2022 “Change the World” list Cosmo Pharmaceuticals N.V.
12-Oct-2022 Gerresheimer AG: Gerresheimer reports double digit growth in revenue and earnings for the third quarter Gerresheimer AG
11-Oct-2022 Abivax: first US patient enrolled in global phase 3 program with obefazimod in ulcerative colitis ABIVAX
11-Oct-2022 Vetter Drives Its Sustainability Campaign Forward B3C newswire
11-Oct-2022 Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan Evonik
11-Oct-2022 Eckert & Ziegler to Build Production Line for NorthStar Medical Radioisotopes’ Dedicated Actinium-225 Production Facility Eckert & Ziegler Strahlen- und Medizintechnik AG
11-Oct-2022 Aptar Digital Health Launches New Digital Disease Management Platform to Better Track Patient Treatment Adherence Aptar Pharma
11-Oct-2022 New data from AlzeCure demonstrate potential disease-modifying effects of NeuroRestore ACD856 AlzeCure
11-Oct-2022 EnteroBiotix receives MHRA MIA (IMP) licensure of state-of-the-art GMP manufacturing facility for producing microbiome therapeutics EnteroBiotix
11-Oct-2022 Muna Therapeutics Awarded $4.9M Grant from The Michael J. Fox Foundation for Parkinson’s Research Muna Therapeutics
11-Oct-2022 Novo Seeds Portfolio Company NMD Pharma Reports Positive Top-Line Phase I/IIa Data in Myasthenia Gravis Novo Holdings
11-Oct-2022 Watson-Marlow introduces KROHNE flowmeter to safeguard accuracy of fluid flow Sciad Newswire
11-Oct-2022 Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting Kuros Biosciences AG
11-Oct-2022 Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting Kuros Biosciences AG